Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/49770
Conference/Presentation Title: Dysfunctional breathing induces vocal cord dysfunction following COVID-19 infection.
Authors: Laurence R.;Joo K.;Malcolm B.;Paul L.;Garun H.;Paul F.;Philip B.
Institution: (Laurence, Joo, Malcolm, Paul, Garun, Paul, Philip) Monash Health, Clayton, Australia
(Laurence, Joo, Paul, Garun, Philip) Monash University, Clayton, Australia
Presentation/Conference Date: 3-May-2023
Copyright year: 2023
Publisher: John Wiley and Sons Inc
Publication information: Respirology. Conference: TSANZSRS 2023 Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health and Respiratory Science. Christchurch New Zealand. 28(Supplement 2) (pp 21), 2023. Date of Publication: March 2023.
Journal: Respirology
Abstract: Introduction/Aim: SARS-CoV-2 (COVID-19) has affected over 60 million people world-wide. In most cases symptoms are mild, however some people have ongoing symptoms lasting longer known as 'long COVID'. Exertional breathlessness is a common complaint in these patients. Dysfunctional breathing (DB) and vocal cord dysfunction (VCD) are two underappreciated causes of breathlessness. We hypothesized that in individuals who had experienced COVID-19, dysfunctional breathing could give rise to VCD. Method(s): Nine convenience-sampled participants with confirmed COVID-19 infection were included following resolution of the acute illness. Vocal cords movements were visualised via continuous laryngoscopy. Hyperventilation was employed as a surrogate for DB, using a standard protocol of 40 breathes per minute (bpm). Participants breathed through a flow sensor with concomitant laryngoscopy, and we monitored hyperventilation, gas exchange measurements and laryngeal movements. After 12-weeks patients returned for repeat hyperventilation testing. Result(s): The nine participants consisted of five females and four males, age range 24-66 years. Three of the nine participants developed classic inspiratory VCD during hyperventilation. Patients with VCD were female, younger (<45), reported significantly reduced exercise tolerance post infection and had been physically very active prior to COVID infection. In two participants VCD associated with hyperventilation had resolved on laryngoscopy at 12-weeks. In these two participants who had VCD, breathlessness and reduced exercise tolerance resolved at 12-weeks following laryngeal retraining. In one person evidence of VCD and reduced exercise tolerance persisted post 12-weeks review. Conclusion(s): This study provides the first evidence that COVID-19 may facilitate VCD via DB, causing unexplained breathlessness. Our findings suggest that this disease process may be implicated in 'long COVID' and provide a rationale for therapies such as breathing and laryngeal retraining.
Conference Name: TSANZSRS 2023 Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health and Respiratory Science
Conference Start Date: 2023-03-25
Conference End Date: 2023-03-28
Conference Location: Christchurch, New Zealand
DOI: http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1111/resp.14458
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/49770
Type: Conference Abstract
Subjects: breathing
coronavirus disease 2019
dyspnea
gas exchange
hyperventilation
laryngoscopy
long COVID
vocal cord
vocal cord disorder
Type of Clinical Study or Trial: Observational study (cohort, case-control, cross sectional, or survey)
Appears in Collections:Conferences

Show full item record

Page view(s)

60
checked on May 24, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.